Apotex Inc. et al. v. Regeneron Pharmaceuticals, Inc. > Summary
Court Case Number IPR2022-01524
Filing Date Sep 9, 2022
Institution Decision Date Mar 10, 2023
Decision Date Mar 10, 2023
Court Patent Trial and Appeal Board
Status Institution Denied
Administrative JudgesErica A. Franklin, John G. New, Susan L. C. Mitchell
Judge Writing the Final DecisionErica A. Franklin
Claims Challenged in the Petition: 1, 3, 4, 5, 6, 7, 8, 9, 10, 11, 13, 14, 16, 17, 18, 19, 20, 21, 22, 23, 24, 26
Petitioner
Patent Owner
Petitioner Attorneys
4Apotex
Attorney Name: Angelo Tanna
Apotex
Apotex
Attorney Name: Teresa Stanek Rea
Crowell & Moring
Apotex
Attorney Name: Shannon M. Lentz
Crowell & Moring
Apotex
Attorney Name: Deborah H. Yellin
Crowell & Moring
Patent Owner Attorneys
5Regeneron Pharmaceuticals
Attorney Name: Adam R. Brausa
Morrison & Foerster
Regeneron Pharmaceuticals
Attorney Name: Kira A. Davis
Morrison & Foerster
Regeneron Pharmaceuticals
Attorney Name: Daralyn J. Durie
Morrison & Foerster
Regeneron Pharmaceuticals
Attorney Name: Richard Manning
Intensity, LLC
Regeneron Pharmaceuticals
Attorney Name: Lucian V. Del Priore
Yale University
Related Patents
Doc No | Title | Issue date |
---|---|---|
11253572 | Use of a VEGF antagonist to treat angiogenic eye disorders | Feb 22, 2022 |